Michael D. Keppen

A phase I study of AT-101 with cisplatin and etoposide in patients with advanced solid tumors with an expanded cohort in extensive-stage small cell lung cancer

William R. Schelman, Tabraiz A Mohammed, Anne M. Traynor et al. · Investigational New Drugs · 2013 · 48 citations · Full text

Medicine, Pathology, Advanced Solid Tumors +5

A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma: A southwest oncology group study

Bernard L. Zidar, Barbara Metch, Stanley P. Balcerzak et al. · Cancer · 1992 · 42 citations

Phase II study of Fludarabine Phosphate in multiple myeloma

Eric H. Kraut, John J. Crowley, Michael R. Grever et al. · Investigational New Drugs · 1990 · 37 citations

Hematological Malignancy, Fludarabine Phosphate, Medicine +5

A phase I study of radiation therapy and twice-weekly gemcitabine and cisplatin in patients with locally advanced pancreatic cancer

James A. Martenson, Antonio P. Vigliotti, Henry C. Pitot et al. · International Journal of Radiation Oncology*Biology*Physics · 2003 · 32 citations

Surgical Oncology, Pancreatic Cancer, Health Sciences +8

Acute Leukemia after Successful Chemotherapy for Oat Cell Carcinoma

Virgil L. Rose, Michael D. Keppen, Edward R. Eichner et al. · American Journal of Clinical Pathology · 1983 · 16 citations

Hematological Malignancy, Medicine, Numerous Blasts +12